XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Schedule of Derivative Liability
       
Risk Free Interest Rate     2.32 %
Expected Term     (0.30) – (2.1) Yrs  
Expected Volatility     841.51 %
Expected Dividends        
Schedule of notes receivable
     
Zander Therapeutics, Inc.   $ 5,396